This topic contains a solution. Click here to go to the answer

Author Question: To minimize the potential for kidney damage associated with giving acyclovir intravenously, the ... (Read 19 times)

abc

  • Hero Member
  • *****
  • Posts: 543
To minimize the potential for kidney damage associated with giving acyclovir intravenously, the nurse will:
 
  1. decrease the client's protein intake two days before and two days after treatment.
  2. hydrate the client intravenously during and for 2 hours after the infusion.
  3. discontinue the infusion if there is any concern about a potential increase in levels of BUN.
  4. limit oral fluids during infusion.

Question 2

The nurse is aware that to achieve the most therapeutic effects, the best time to administer oseltamivir (Tamiflu) or zanamivir (Relenza) is:
 
  1. as soon as the client has been exposed to someone with influenza.
  2. any time during the course of the illness.
  3. at the same time as the vaccine.
  4. within 48 hours of the onset of symptoms.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jsm54321

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

Correct Answer: 2
Rationale 1: When given IV, acyclovir is associated with nephrotoxicity, but decreasing protein intake will not decrease the potential for kidney damage.
Rationale 2: When given IV, acyclovir is associated with nephrotoxicity, so ensuring that the infusion is administered slowly and that the client is properly hydrated can lessen the potential for IV toxicity.
Rationale 3: Monitoring BUN levels is important, but another intervention is more crucial to decreasing the risk of kidney damage.
Rationale 4: When given IV, acyclovir is associated with nephrotoxicity. Oral fluids should not be limited.
Global Rationale: When given IV, acyclovir is associated with nephrotoxicity, so ensuring that the infusion is administered slowly and that the client is properly hydrated can lessen the potential for IV toxicity. Decreasing protein will have no effect. Monitoring BUN levels is important but will not prevent damage. Oral fluids should not be limited.

Answer to Question 2

Correct Answer: 4
Rationale 1: Oseltamivir (Tamiflu) and zanamivir (Relenza) should be given within 48 hours of the onset of symptoms.
Rationale 2: When oseltamivir and zanamivir are given within 48 hours of the onset of symptoms, their use can shorten the normal 7-day course of influenza to 5 days.
Rationale 3: Oseltamivir (Tamiflu) and zanamivir (Relenza) should be given within 48 hours of the onset of symptoms, not at the same time as the vaccine.
Rationale 4: Oseltamivir (Tamiflu) and zanamivir (Relenza) are examples of a new classification of drugs called neuraminidase inhibitors that are used to treat active influenza infection. When given within 48 hours of the onset of symptoms, their use can shorten the normal 7-day course of influenza to 5 days.
Global Rationale: Given within 48 hours of the onset of symptoms, the two neuraminidase inhibitors, oseltamivir (Tamiflu) and zanamivir (Relenza), will shorten the normal 7-day duration of influenza symptoms to 5 days.




abc

  • Member
  • Posts: 543
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


31809pancho

  • Member
  • Posts: 317
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library